Study Progression of Apelin/APJ Signaling and Apela in Different Types of Cancer

Apelin is an endogenous ligand that binds to the G protein-coupled receptor angiotensin-like-receptor 1 (APJ). Apelin and APJ are widely distributed in organs and tissues and are involved in multiple physiological and pathological processes including cardiovascular regulation, neuroendocrine stress...

Full description

Bibliographic Details
Main Authors: Longfei Liu, Xiaoping Yi, Can Lu, Yong Wang, Qiao Xiao, Liang Zhang, Yingxian Pang, Xiao Guan
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-04-01
Series:Frontiers in Oncology
Subjects:
APJ
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.658253/full
id doaj-1baa585eb2b6407a9ca688f48e090f2c
record_format Article
spelling doaj-1baa585eb2b6407a9ca688f48e090f2c2021-04-12T05:38:18ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2021-04-011110.3389/fonc.2021.658253658253Study Progression of Apelin/APJ Signaling and Apela in Different Types of CancerLongfei Liu0Xiaoping Yi1Can Lu2Yong Wang3Qiao Xiao4Liang Zhang5Yingxian Pang6Xiao Guan7Department of Urology, Xiangya Hospital, Central South University, Changsha, ChinaDepartment of Radiology, Xiangya Hospital, Central South University, Changsha, ChinaDepartment of Nephrology, The Second Xiangya Hospital of Central South University, Changsha, ChinaDepartment of Urology, Xiangya Hospital, Central South University, Changsha, ChinaDepartment of Urology, Xiangya Hospital, Central South University, Changsha, ChinaDepartment of Urology, Xiangya Hospital, Central South University, Changsha, ChinaDepartment of Urology, Xiangya Hospital, Central South University, Changsha, ChinaDepartment of Urology, Xiangya Hospital, Central South University, Changsha, ChinaApelin is an endogenous ligand that binds to the G protein-coupled receptor angiotensin-like-receptor 1 (APJ). Apelin and APJ are widely distributed in organs and tissues and are involved in multiple physiological and pathological processes including cardiovascular regulation, neuroendocrine stress response, energy metabolism, etc. Additionally, apelin/APJ axis was found to play an important role in cancer development and progression. Apela is a newly identified endogenous ligand for APJ. Several studies have revealed the potential role of Apela in cancers. In this article, we review the current studies focusing on the role of apelin/APJ signaling and Apela in different cancers. Potential mechanisms by which apelin/APJ and Apela mediate the regulation of cancer development and progression were also mentioned. The Apelin/APJ signaling and Apela may serve as potential therapeutic candidates for treatment of cancer.https://www.frontiersin.org/articles/10.3389/fonc.2021.658253/fullapelinAPJApelacancertherapeutic targets
collection DOAJ
language English
format Article
sources DOAJ
author Longfei Liu
Xiaoping Yi
Can Lu
Yong Wang
Qiao Xiao
Liang Zhang
Yingxian Pang
Xiao Guan
spellingShingle Longfei Liu
Xiaoping Yi
Can Lu
Yong Wang
Qiao Xiao
Liang Zhang
Yingxian Pang
Xiao Guan
Study Progression of Apelin/APJ Signaling and Apela in Different Types of Cancer
Frontiers in Oncology
apelin
APJ
Apela
cancer
therapeutic targets
author_facet Longfei Liu
Xiaoping Yi
Can Lu
Yong Wang
Qiao Xiao
Liang Zhang
Yingxian Pang
Xiao Guan
author_sort Longfei Liu
title Study Progression of Apelin/APJ Signaling and Apela in Different Types of Cancer
title_short Study Progression of Apelin/APJ Signaling and Apela in Different Types of Cancer
title_full Study Progression of Apelin/APJ Signaling and Apela in Different Types of Cancer
title_fullStr Study Progression of Apelin/APJ Signaling and Apela in Different Types of Cancer
title_full_unstemmed Study Progression of Apelin/APJ Signaling and Apela in Different Types of Cancer
title_sort study progression of apelin/apj signaling and apela in different types of cancer
publisher Frontiers Media S.A.
series Frontiers in Oncology
issn 2234-943X
publishDate 2021-04-01
description Apelin is an endogenous ligand that binds to the G protein-coupled receptor angiotensin-like-receptor 1 (APJ). Apelin and APJ are widely distributed in organs and tissues and are involved in multiple physiological and pathological processes including cardiovascular regulation, neuroendocrine stress response, energy metabolism, etc. Additionally, apelin/APJ axis was found to play an important role in cancer development and progression. Apela is a newly identified endogenous ligand for APJ. Several studies have revealed the potential role of Apela in cancers. In this article, we review the current studies focusing on the role of apelin/APJ signaling and Apela in different cancers. Potential mechanisms by which apelin/APJ and Apela mediate the regulation of cancer development and progression were also mentioned. The Apelin/APJ signaling and Apela may serve as potential therapeutic candidates for treatment of cancer.
topic apelin
APJ
Apela
cancer
therapeutic targets
url https://www.frontiersin.org/articles/10.3389/fonc.2021.658253/full
work_keys_str_mv AT longfeiliu studyprogressionofapelinapjsignalingandapelaindifferenttypesofcancer
AT xiaopingyi studyprogressionofapelinapjsignalingandapelaindifferenttypesofcancer
AT canlu studyprogressionofapelinapjsignalingandapelaindifferenttypesofcancer
AT yongwang studyprogressionofapelinapjsignalingandapelaindifferenttypesofcancer
AT qiaoxiao studyprogressionofapelinapjsignalingandapelaindifferenttypesofcancer
AT liangzhang studyprogressionofapelinapjsignalingandapelaindifferenttypesofcancer
AT yingxianpang studyprogressionofapelinapjsignalingandapelaindifferenttypesofcancer
AT xiaoguan studyprogressionofapelinapjsignalingandapelaindifferenttypesofcancer
_version_ 1721530224521248768